US Officials Concede No Active Surveillance on Long-Term Effects of COVID-19 Vaccines

A congressional subcommittee questioned CDC and FDA officials over efforts to monitor adverse events that may still manifest from original COVID-19 vaccines.

Select Subcommittee on the Coronavirus Pandemic, Screenshot via The Epoch Times

In a Feb. 15 hearing by the Select Subcommittee on the Coronavirus Pandemic, U.S. health officials side-stepped a question when asked whether the U.S. Food and Drug Administration (FDA) is actively conducting extended safety surveillance on those who received early COVID-19 vaccines.

Rep. Nicole Malliotakis (R-N.Y.) asked Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, whether the FDA is conducting active surveillance and if there are any specific health markers they’re studying that may signal trends requiring further inquiry.